ImageneBio Inc
27 hedge funds and large institutions have $539M invested in ImageneBio Inc in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
5.34% more ownership
Funds ownership: 0% → 5.34% (+5.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$108M |
| 2 |
O
OrbiMed
New York
|
+$83.7M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$64.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$58.6M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$45.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MS
26
Maven Securities
St Helier,
Jersey
| $248K | +$280K | +817 | New |
|
27
UBS Group
Zurich,
Switzerland
| $27K | +$27.7K | +81 | New |
|
IMA Hedge Fund Activity: Q1 2021 in Review
27 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2021, worth a combined $539M.
Buyers outnumbered sellers: 27 funds opened new IMA positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $108M.
- 27 institutional investors held ImageneBio Inc (IMA) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $539M of ImageneBio Inc stock for Q1 2021.
- 27 funds opened new ImageneBio Inc positions in Q1 2021 and 0 closed out, a net change of +27 holders.
- The largest ImageneBio Inc buyer in Q1 2021 was Fidelity Investments, an estimated $108M added.
Based on aggregated 13F filings for Q1 2021.